Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC.
Liang X, Zhang W, Li J, Zhu J, Shao J, Wang J, Wu H, Dai J, Li J, Xu J, Wang W, Guo R.
Liang X, et al.
J Cancer Res Clin Oncol. 2023 Mar;149(3):1211-1220. doi: 10.1007/s00432-022-03952-z. Epub 2022 Apr 5.
J Cancer Res Clin Oncol. 2023.
PMID: 35380256